患有低毒性缺血性脑病变的早产婴儿中与拉科萨米德相关的心脏功能障碍:一个病例报告
Trassanee Chatmethakul1,2, Amy H Stanford2, Danielle R Rios2
1Department of Pediatrics, Neonatal-Perinatal Medicine Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
AJP reports
|November 27, 2024
概括
拉科萨米德是一种抗发作药物,可能对早产婴儿构成风险. 一个案例研究详细介绍了一个早产新生儿在开始lacosamide治疗后出现左心室功能障碍.
科学领域:
- 新生儿药理学 新生儿药理学
- 儿科心脏病学 儿科心脏病学
- 临床神经学 临床神经学
背景情况:
- 拉科萨米德是一种被批准用于成人和儿童的抗发作药物,作用于电压关闭的通道.
- 它在新生儿中的使用基于成人/儿科数据,这表明它具有良好的安全性.
- 过早出生的婴儿具有独特的生理特征,这可能会增加对药物不良反应的敏感性.
研究的目的:
- 报告一个早产新生儿用lacosamide治疗的潜在心脏不良影响的病例.
- 强调需要对接受lacosamide的早产婴儿进行仔细监测.
主要方法:
- 一个早产新生儿的案例报告.
- 在lacosamide治疗期间对心脏功能进行临床观察和评估.
主要成果:
- 过早出生的新生儿出现了左心室功能障碍.
- 这次心脏事件与拉科萨米德治疗的开始相吻合.
结论:
- 由于潜在的心脏风险,在早产新生儿中使用lacosamide需要谨慎.
- 需要进一步的研究来评估lacosamide在这个脆弱人群中的安全性.
相关概念视频
Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Diabetic Ketoacidosis l: Introduction
41
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
41
Diabetic Ketoacidosis ll: Pathophysiology
41
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
41


